BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15649186)

  • 1. Novel pharmacological approaches in the treatment of psoriasis.
    Schleyer V; Landthaler M; Szeimies RM
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):1-20. PubMed ID: 15649186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of new biological therapy in psoriasis treatment].
    Cortijo Cascajares S; García Rodríguez MP; Campo Angora M; Serrano Garrote O; Herreros de Tejada A
    Farm Hosp; 2004; 28(3):192-200. PubMed ID: 15222873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis: from pathogenesis to novel therapeutic approaches.
    Monteleone G; Pallone F; MacDonald TT; Chimenti S; Costanzo A
    Clin Sci (Lond); 2011 Jan; 120(1):1-11. PubMed ID: 20846119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences.
    Kormeili T; Lowe NJ; Yamauchi PS
    Br J Dermatol; 2004 Jul; 151(1):3-15. PubMed ID: 15270867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of biologicals in psoriasis].
    Friedrich M; Philipp S; Sabat R; Asadullah K; Sterry W
    Z Rheumatol; 2003 Oct; 62(5):439-49. PubMed ID: 14579031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
    Tzu J; Kerdel F
    Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis treatment: traditional therapy.
    Lebwohl M; Ting PT; Koo JY
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii83-6. PubMed ID: 15708945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developments in systemic immunomodulatory therapy for psoriasis.
    Berger EM; Gottlieb AB
    Curr Opin Pharmacol; 2007 Aug; 7(4):434-44. PubMed ID: 17627886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathogenesis of psoriasis.
    Lee MR; Cooper AJ
    Australas J Dermatol; 2006 Aug; 47(3):151-9. PubMed ID: 16866993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus ointment 0.1% alone and in combination with medium-dose UVA1 in the treatment of palmar or plantar psoriasis.
    Rivard J; Janiga J; Lim HW
    J Drugs Dermatol; 2006 Jun; 5(6):505-10. PubMed ID: 16774101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept for psoriasis: two case reports.
    Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
    Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in the treatment of psoriasis.
    Rogers S
    Ir Med J; 1997; 90(5):178-9. PubMed ID: 9345825
    [No Abstract]   [Full Text] [Related]  

  • 13. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
    Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis: a fresh look.
    Galadari I; Sharif MO; Galadari H
    Clin Dermatol; 2005; 23(5):491-502. PubMed ID: 16179183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From laboratory to clinic: rationale for biologic therapy.
    Mehlis S; Gordon KB
    Dermatol Clin; 2004 Oct; 22(4):371-7, vii-viii. PubMed ID: 15450333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The biological treatments for moderate to severe plaque psoriasis].
    Thielen AM; Marazza G
    Rev Med Suisse; 2008 Apr; 4(155):1089-90, 1092-4. PubMed ID: 18610721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concepts for immune intervention in psoriasis vulgaris].
    Nestle FO
    Praxis (Bern 1994); 2000 Sep; 89(37):1468-70. PubMed ID: 11037618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psoriasis: pathogenesis and treatment].
    Heenen M
    Rev Med Brux; 2003 Jun; 24(3):139-47. PubMed ID: 12891880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.